Alzheimer's Disease - San Francisco CA

Summary:

Click image to enlarge

Cognito Therapeutics is designing a novel non-invasive medical device that is under investigation to see if it can slow the impact of Alzheimer’s disease. The goal of this study is to get feedback on prototypes of the medical device.

The study session is a one-time, 90-minute, in-person interview either at our office in downtown San Francisco or at your home (within 1 hour of San Francisco). Your feedback will help us improve features of the device and help us improve potential therapeutics for Alzheimer's disease.

If you might be eligible, you will be contacted for a phone call to discuss the study details and answer additional eligibility questions to see if you qualify for an in-person interview.

Qualified Participants Must:

• Have a diagnosis of or memory changes possible due to mild or moderate Alzheimer's Disease, or Mild Cognitive Impairment
• Be at least 50 years old
• Speak English

Qualified Participants May Receive:

Should you be eligible and complete a 90-minute interview, a $150 honorarium will be provided to compensate you for your time.

Should you have a care partner (family member or friend) that participates in the study with you, they will also be provided with a $150 honorarium to compensate them for their time.